Abstract:Abstract Background Rapid, reagent-free pathogen-agnostic diagnostics that can be performed at the point of need are vital for preparedness against future outbreaks. Yet, many current strategies (polymerase chain reaction, lateral flow immunoassays) are pathogen-specific and require reagents; whereas others such as sequencing-based methods; while agnostic, are not (as yet) conducive for use at the point of need. Herein, we present hyperspectral sensing as an opportunity to overcome these barriers, realizing truly agnostic reagent-free diagnostics. This approach can identify both pathogen and host signatures, without complex logistical considerations, in complex clinical samples. The spectral signature of biomolecules across multiple wavelength regimes provides rich biochemical information, which, coupled with machine learning, can facilitate expedited diagnosis of disease states, the feasibility of which is demonstrated here. Innovation First, we present ProSpectral(TM) V1, a novel, miniaturized (~8 lbs) hyperspectral platform with ultra-high (2-5 nm full-width, half-max, i.e., FWHM) spectral resolution that incorporates two mini-spectrometers (visual and near-infrared). This engineering innovation has enabled reagent-free biosensing for the first time. To enable expedient outcomes, we developed state-of-the-art machine learning algorithms for near real-time analysis of multi-wavelength spectral signatures in complex samples. Taken together, these innovations enable near-field ready, reagent-free, expedient agnostic diagnostics in complex clinical samples. Herein, we demonstrate the feasibility of this synergy of ProSpectral(TM) V1 with machine learning to accurately identify SARS-CoV-2 infection status in double-blinded saliva samples in real-time (3 seconds/measurement). The infection status of the samples was validated with the CDC-approved polymerase-chain reaction (PCR). We report accuracies comparable to first-in-class PCR tests. Further, we provide preliminary support that this signal is specific to SARS-CoV-2, and not associated with other respiratory conditions. Interpretation Preparedness against unanticipated pathogens and democratization of diagnostics requires moving away from technologies that demand specific reagents; and relying on intrinsic biochemical properties that can, theoretically, inform on all pathologies. Integration of hyperspectral sensors and in-line machine learning analytics, as reported here, shows the feasibility of such diagnostics. If realized to full potential, the ProSpectral(TM) V1 platform can enable agnostic diagnostics, thereby improving situational awareness and decision-making at the point of need; especially in resource-limited settings - enabling the distribution of newly developed tests for emerging pathogens with only a simple software update. Funding The U.S. Department of Energy, the Defense Threat Reduction Agency, Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, and Pattern Computer Inc.

An integrated computational pipeline for machine learning-driven diagnosis based on Raman spectra of saliva samples

P263 Raman spectroscopy analysis of saliva combined with an artificial neural network algorithm could discriminate between Ulcerative Colitis and Crohn’s disease

Liquid saliva-based Raman spectroscopy device with on-board machine learning detects COVID-19 infection in real-time

A Feasibility Study of Early Detection of Lung Cancer by Saliva Test Using Surface Enhanced Raman Scattering

Label-Free SERS and MD Analysis of Biomarkers for Rapid Point-of-Care Sensors Detecting Head and Neck Cancer and Infections

Harnessing topological machine learning in Raman spectroscopy: Perspectives for Alzheimer's disease detection via cerebrospinal fluid analysis

Raman spectroscopy-based detection of RNA viruses in saliva: A preliminary report

Alzheimer Disease Detection from Raman Spectroscopy of the Cerebrospinal Fluid via Topological Machine Learning

MALDI(+) FT-ICR Mass Spectrometry (MS) Combined with Machine Learning toward Saliva-Based Diagnostic Screening for COVID-19

Non-invasive Disease Diagnosis Using Surface-Enhanced Raman Spectroscopy of Urine and Saliva

Diagnosis of Parkinson's Disease via the Metabolic Fingerprint in Saliva by Deep Learning

Data Mining Methods of Lung Cancer Diagnosis by Saliva Tests Using Surface Enhanced Raman Spectroscopy

SERS-based biosensor for Alzheimer disease evaluation through the fast analysis of human serum

Non-invasive diagnostic test for lung cancer using biospectroscopy and variable selection techniques in saliva samples

Multi-scale sequential feature selection for disease classification using Raman spectroscopy data

Reagent-free Hyperspectral Diagnosis of SARS-CoV-2 Infection in saliva samples

Discrimination of Genetic Biomarkers of Disease through Machine-Learning-Based Hypothesis Testing of Direct SERS Spectra of DNA and RNA

A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics

Multi-configuration Raman Spectrometer for Early Stage Diagnosis of Oral Cancer

Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning

Rapid diagnosis of lung cancer and glioma based on serum Raman spectroscopy combined with deep learning